Results 21 to 30 of about 4,607,099 (394)

Mandatory Access Prescription Drug Monitoring Programs and Prescription Drug Abuse

open access: yesJournal of policy analysis and management, 2017
Despite the significant cost of prescription (Rx) drug abuse and calls from policymakers for effective interventions, there is limited research on the effects of policies intended to limit such abuse. This study estimates the effects of prescription drug
Dhaval M. Dave   +2 more
semanticscholar   +1 more source

Crystal structure of (E)-2-((3-fluoropyridin-4-yl)methylene)-7-methoxy-3,4-dihydronaphthalen-1(2H)-one, C17H14FNO2

open access: yesZeitschrift für Kristallographie - New Crystal Structures, 2021
C17H14FNO2, monoclinic, P21/n (no. 14), a = 8.0937(8) Å, b = 7.1326(6) Å, c = 22.367(2) Å, β = 90.863(9)°, V = 1291.1(2) Å3, Z = 4, Rgt(F) = 0.0404, wRref(F2) = 0.0974, T = 99.97(16) K.
Wang Chen   +5 more
doaj   +1 more source

Evaluation of prescription writing skills of medical professional practicing in varanasi city: A cross-sectional survey

open access: yesJournal of Indian Association of Public Health Dentistry, 2023
Objective: Prescription writing is an integral part of medical profession. Incorrect prescription writing may lead to errors in instructions about the identity of the recipient, the identity of the drug, the formulation, dose, route, timing, frequency ...
Ananta Kusumakar   +4 more
doaj   +1 more source

Prescription drug forms with midazolam [PDF]

open access: yesFarmacja Polska, 2021
Midazolam is a benzodiazepine derivative. It is characterized by a short half-life. It has a strong sedative, anxiolytic and hypnotic effect. It also acts as an anticonvulsant and relaxes skeletal muscles.
Anna Czech, Renata Jachowicz
doaj   +1 more source

Assessing The Impact Of State Policies For Prescription Drug Monitoring Programs On High-Risk Opioid Prescriptions.

open access: yesHealth Affairs, 2018
Policies and practices have proliferated to optimize prescribers' use of their states' prescription drug monitoring programs, which are statewide databases of controlled substances dispensed at retail pharmacies.
Y. Bao   +5 more
semanticscholar   +1 more source

Shift work and use of psychotropic medicine: a follow-up study with register linkage

open access: yesScandinavian Journal of Work, Environment & Health, 2020
OBJECTIVE: This study aimed to investigate a prospective association between shift work and use of psychotropic medicine. METHODS: Survey data from random samples of the general working population of Denmark (N=19 259) were linked to data from national ...
Karen Albertsen   +3 more
doaj   +1 more source

Notoginsenoside R1 Improves Cerebral Ischemia/Reperfusion Injury by Promoting Neurogenesis via the BDNF/Akt/CREB Pathway

open access: yesFrontiers in Pharmacology, 2021
Notoginsenoside R1 (R1), a major component isolated from P. notoginseng, is a phytoestrogen that exerts many neuroprotective effects in a rat model of ischemic stroke.
Ting Zhu   +22 more
doaj   +1 more source

Prevalence of drug-herb and drug-supplement interactions in older adults : A cross-sectional survey [PDF]

open access: yes, 2018
© British Journal of General PracticeBackground Polypharmacy is common among older adults, with increasing numbers also using prescription drugs with herbal medicinal products (HMPs) and dietary supplements.
Agbabiaka   +19 more
core   +2 more sources

Prescription Drug Monitoring Programs, Opioid Abuse, and Crime

open access: yesSouthern Economic Journal, 2018
We study the spillover effects of prescription drug monitoring programs (PDMPs) on crime, and in the process inform how policies that restrict access to Rx opioids per se within the healthcare system would impact broader non-health domains.
Dhaval M. Dave   +2 more
semanticscholar   +1 more source

Crystal structure and anti-inflammatory activity of (3E,5E)-3,5-bis(4-fluorobenzylidene)-1-((4-fluorophenyl)sulfonyl)piperidin-4-one-dichloromethane (1/1), C26H20Cl2F3NO3S

open access: yesZeitschrift für Kristallographie - New Crystal Structures, 2020
C26H20Cl2F3NO3S, triclinic, P1̄ (no. 2), a = 8.5616(4) Å, b = 11.6052(6) Å, c = 14.1451(8) Å, α = 66.617(6)°, β = 82.391(4)°, γ = 69.072(4)°, V = 1204.85(12) Å3, Z = 2, Rgt(F) = 0.0460, wRref(F2) = 0.1206, T = 100.00(10) K.
Yan Wei-Bin   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy